Endovia Health Sciences, Inc. (EDVA) Revenue History
Annual and quarterly revenue from 2013 to present
EDVA Revenue Over Time (2013–2025)
EDVA Revenue Growth History
8 of 12 years with positive growth- FY2013 revenue growth
- N/A
- FY2014 revenue growth
- +27.5%
- FY2015 revenue growth
- +48.1%
- FY2016 revenue growth
- +12.8%
- FY2017 revenue growth
- -11.6%
- FY2018 revenue growth
- +46.2%
- FY2019 revenue growth
- -22.3%
- FY2020 revenue growth
- +126.0%
- FY2021 revenue growth
- +392.0%
- FY2022 revenue growth
- +59.8%
- FY2023 revenue growth
- +4.2%
- FY2024 revenue growth
- -78.0%
- FY2025 revenue growth
- -98.2%
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $0 | — |
| Q1 2026 | $4K | -99.0% |
| Q4 2025 | $-365,206 | -162.3% |
| Q3 2025 | $0 | -100.0% |
| Q2 2025 | $0 | -100.0% |
| Q1 2025 | $438K | -71.6% |
| Q4 2024 | $586K | -78.2% |
| Q3 2024 | $982K | -80.9% |
Multi-year avg. share of annual revenue by fiscal quarter
Revenue Breakdown (FY 2025)
EDVA's revenue distribution by segment and geography for fiscal year 2025
By Product/Segment
EDVA Revenue Analysis (2013–2025)
Current Revenue & Growth
As of November 8, 2026, Endovia Health Sciences, Inc. (EDVA) generated trailing twelve-month (TTM) revenue of $-360,982. The most recent quarter (Q2 2026) recorded $0 in revenue, down 100.0% sequentially.
Historical Growth Trajectory
EDVA's 5-year compound annual growth rate (CAGR) stands at -49.8%, indicating revenue contraction over this period. The 3-year CAGR of -84.1% is below the 5-year average, signalling a growth deceleration in recent years. Endovia Health Sciences, Inc.'s highest annual revenue of $18.9 million was recorded in 2023.
Revenue by Segment
EDVA's revenue is primarily driven by E Commerce (81%), and Splash Beverage Group (19%). With over half of revenue concentrated in E Commerce, the company has a focused business model while developing other growth vectors.
Peer Comparison
Compared to Healthcare sector peers — including FIZZ (-1.8% YoY), CELH (+49.1% YoY), and SAM (+6.2% YoY). Compare EDVA vs FIZZ →
EDVA Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| EDVACurrent | $-360,982 | - | -49.8% | -19415.6% | |
 FIZZ | $1.2B | -1.8% | +1.9% | 19.5% | |
 CELH | $2.5B | +49.1% | +80.7% | 5.6% | |
 SAM | $2.1B | +6.2% | +3.7% | 6.9% | |
 MNST | $8.3B | +20.2% | +12.5% | 29.2% | |
 COKE | $7.2B | +10.2% | +7.6% | 13.2% |
EDVA Historical Revenue Data (2013–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $73K | -98.2% | $17K | 23.1% | $-14,186,220 | -19415.6% |
| 2024 | $4.2M | -78.0% | $355K | 8.6% | $-16,046,236 | -386.2% |
| 2023 | $18.9M | +4.2% | $5.6M | 29.5% | $-15,286,658 | -81.1% |
| 2022 | $18.1M | +59.8% | $5.9M | 32.7% | $-21,394,633 | -118.3% |
| 2021 | $11.3M | +392.0% | $2.6M | 22.8% | $-29,082,922 | -257.0% |
| 2020 | $2.3M | +126.0% | $364K | 15.8% | $-17,661,766 | -767.9% |
| 2019 | $1.0M | -22.3% | $509K | 50.0% | $-470,396 | -46.2% |
| 2018 | $1.3M | +46.2% | $704K | 53.8% | $67K | 5.1% |
| 2017 | $895K | -11.6% | $455K | 50.8% | $-157,206 | -17.6% |
| 2016 | $1.0M | +12.8% | $527K | 52.1% | $-50,001 | -4.9% |
| 2015 | $897K | +48.1% | $470K | 52.4% | $19K | 2.1% |
| 2014 | $606K | +27.5% | $350K | 57.7% | $-27,878 | -4.6% |
| 2013 | $475K | - | $239K | 50.3% | $618 | 0.1% |
EDVA Chart Terminal
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
Live Breakouts Feed
High-probability breakout stocks crossing their pivot across 5 pattern engines.
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
13+ years return with dividends reinvested.
Peer Comparison
Compare growth, multiples, and margins vs sector.
EDVA — Frequently Asked Questions
Quick answers to the most common questions about buying EDVA stock.
Is EDVA's revenue growth accelerating or slowing?
EDVA TTM revenue: $-360982.00. YoY growth: N/A. 5-year CAGR: -49.8%.
What is EDVA's revenue history from 2013 to 2026?
Endovia Health Sciences, Inc. (EDVA) revenue history spans 2013 to 2026. TTM revenue as of 2026 is $-360982.00, growing at N/A YoY. The 5-year CAGR is -49.8%. Complete annual and quarterly revenue figures are available on this page, including gross profit, operating income, and margin trends.
What is EDVA's long-term revenue growth rate (CAGR)?
Endovia Health Sciences, Inc.'s 5-year revenue CAGR of -49.8% reflects the variable nature of its business expansion. As of 2026, the current YoY growth rate of N/A is in line with this long-term average. CAGR is the most reliable measure of sustained revenue momentum for EDVA.
Why does EDVA's quarterly revenue fluctuate?
EDVA quarterly revenue can fluctuate significantly between periods. A quarter-over-quarter (QoQ) change does not always indicate a trend; comparing the same quarter year-over-year (YoY) is a more reliable signal for underlying growth. Endovia Health Sciences, Inc.'s revenue data from 2013 to 2026 shows full historical quarterly detail on this page.
How is EDVA's revenue distributed by segment?
EDVA reports revenue broken down by product line and geographic region. The segment breakdown on this page shows which business units contribute the most to total revenue as of the latest fiscal year. Concentration in a single segment above 50% indicates category dependence, while a diversified mix signals more resilient revenue streams.
How does EDVA's revenue compare to industry peers?
Endovia Health Sciences, Inc. (EDVA) with TTM revenue of $-360982.00 and N/A YoY growth can be benchmarked against sector peers using the comparison table on this page. Revenue growth relative to peers indicates market share gains or losses. The peer section shows TTM revenue, YoY growth, and operating margin for direct comparisons.